Lower functional gastrointestinal disorders: Evidence of abnormal colonic transit in a 287 patient cohort

Neurogastroenterology and Motility

Volumn 22, Issue 3, 2010, Pages

  Manabe, N ^a   Wong, B S ^a   Camilleri, M ^a   Burton, D ^a   McKinzie, S ^a   Zinsmeister, A R ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Constipation; Diarrhoea; Irritable bowel; Motility

Indexed keywords

TECHNETIUM 99M;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; COHORT ANALYSIS; COLON MOTILITY; CONSTIPATION; CONTROLLED STUDY; DATA BASE; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; EGG; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; GASTROINTESTINAL TRANSIT; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COLON; COLONIC DISEASES, FUNCTIONAL; CONSTIPATION; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; HUMANS; MALE; PATIENT SELECTION; SEX FACTORS;

EID: 76349097992     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01442.x     Document Type: Article

References (48)

1. Lee KT, Rhee PL, Kim J et al. Assessment of autonomic tone over a 24-hour period in patients with irritable bowel syndrome (abstr). Gastroenterology 1997 112 : A773.
2. Everhart JE, Renault PF. Irritable bowel syndrome in office based practice in the United States. Gastroenterology 1991 100 : 988 1005.
3. Levy RL, Stang P, von Korff M et al. Longitudinal study of the comparative costs of IBS in an HMO (abstr). Am J Gastroenterol 2000 95 : A2540.
4. Camilleri M. Motor function in irritable bowel syndrome. Can J Gastroenterol 1999 13 (Suppl A 8A 11A.
5. Harraf F, Schmulson M, Saba L et al. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut 1998 43 : 388 394.
6. Rao SS, Ozturk R, De Ocampo S et al. Clinical utility of diagnostic tests for constipation in adults: a systemic review. Am J Gastroenterol 2005 100 : 1605 1615.
7. Mertz H, Naliboff B, Mayer EA et al. Symptoms and physiology in severe chronic constipation. Am J Gastroenterol 1999 94 : 131 138. (Pubitemid 29063456)
8. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology 1992 103 : 36 42.
9. Vassallo M, Camilleri M, Phillips SF et al. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology 1992 102 : 102 108.
10. Flegal KM, Carroll MD, Odgen CL et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002 288 : 1723 1727.
11. Delgado-Aros S, Locke GR, Camilleri M et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 2004 99 : 1801 1806.
12. Talley NJ, Howel S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol 2004 99 : 1807 1814.
13. Talley NJ, Quan C, Jones MP et al. Association of upper and lower gastrointestinal symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil 2004 16 : 413 419.
14. Proano M, Camilleri M, Phillips SF et al. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol 1990 258 : G856.
15. Burton DD, Camilleri M, Mullan BP et al. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med 1997 38 : 1807 1810.
16. Cremonini F, Mullan BP, Camilleri M et al. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002 16 : 1781 1790.
17. Bennett EJ, Evans P, Scott AM et al. Psychological and sex features of delayed gut transit in functional gastrointestinal disorders. Gut 2000 46 : 83 7.
18. Bouchoucha M, Devroede G, Dorval E et al. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms? Tech Coloproctol 2006 10 : 287 296.
19. Sadik R, Stotzer PO, Simren M et al. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary center. Neurogastroenterol Motil 2008 20 : 197 205.
20. Cann PA, Read NW, Brown C et al. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom pattern. Gut 1983 24 : 405 411.
21. Stivland T, Camilleri M, O'Brien MD et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991 101 : 107 115.
22. Debongnie JC, Phillips SF. Capacity of the human colon to absorb fluid. Gastroenterology 1978 74 : 698 703.
23. Thompson WG, Longstreth G, Drossman DA et al. Functional bowel disorders and functional abdominal pain. In : Drossman DA, Corazziari E, Talley NJ et al., eds. Rome II: The Functional Gastrointestinal Disorders. 2nd Ed. McLean, VA : Degnon Associates, 2000 : 351 432.
24. Posserud I, Stotzer PO, Bjomsson ES et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007 56 : 802 808.
25. Bulpitt CJ, Palmer AJ, Battersby C et al. Association of symptoms of type II diabetic patients with severity of disease, obesity, and blood pressure. Diabetes Care 1998 21 : 111 115.
26. Delgado-Aros S, Camilleri M, Garcia MA et al. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol 2008 295 : G382 8.
27. Bertin E, Schneider N, Abdelli N et al. Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. Diabetes Metab 2001 27 : 357 364.
28. Verdich C, Madsen JL, Toubro S et al. Effect of obesity and major weight reduction on gastric emptying. Int J Obes Relat Metab Disord 2000 24 : 899 905.
29. Miettinen TA. Cholesterol production in obesity. Circulation 1971 44 : 842 850.
30. Reuben A, Qureshi Y, Murphy GM et al. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid. Eur J Clin Invest 1986 16 : 133 142.
31. Sadik R, Abrahamsson H, Ung KA et al. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol 2004 99 : 711 718.
32. Simren M, Mansson A, Langkilde AM et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001 163 : 108 115.
33. Camilleri M, McKinzie S, Busciglio I et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008 6 : 772 781.
34. Choi MG, Camilleri M, O'Brien MD, Kammer PP, Hanson RB. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol 1997 92 : 297 302.
35. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001 96 : 1499 1506.
36. Cook IJ, Furukawa Y, Panagopoulos V, Collins PJ, Dent J. Relationships between spatial patterns of colonic pressure and individual movements of content. Am J Physiol 2000 278 : G329 41.
37. Longstreth GF, Thompson WG, Houghton LA et al. Functional bowel disorders. In : Drossman DA, Corazziari E, Delvaux M et al., eds. Rome III: The Functional Gastrointestinal Disorders. 3rd Ed. McLean, VA : Degnon Associates, 2006 : 487 555.
38. Mearin F, Balboa A, Badia X et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003 15 : 165 172.
39. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997 32 : 920 924.
40. Mearin F, Baró E, Roset M et al. Clinical pattern over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004 99 : 113 121.
41. Levy R, Linde JA, Feld KA et al. The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol 2005 3 : 992 996.
42. Heaton KW, Radvan J, Cripps H et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 1992 33 : 818 824.
43. Viramontes BE, Camilleri M, McKinzie S et al. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001 96 : 2671 2676.
44. Prather CM, Camilleri M, Zinsmeister AR et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000 118 : 463 468. (Pubitemid 30140843)
45. Bouras EP, Camilleri M, Burton DD et al. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology 2001 120 : 354 360.
46. Camilleri M, Kerstens R, Rykx A et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008 29 : 2344 2354.
47. Camilleri M, Chang L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology 2008 135 : 1877 1891.
48. Deiteren A, Camilleri M, Bharucha AE et al. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil 2009 in press (doi :).